Director/PDMR Shareholding

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. PLEASE COMPLETE ALL RELEVANT BOXES IN BLOCK CAPITAL LETTERS. 1. Name of the issuer: THE BIOTECH GROWTH TRUST PLC 2. State whether the notification relates to: (i) a transaction notified in accordance with DR 3.1.2R; or (ii) a disclosure made in accordance with LR9.8.6R(1); or (iii) a disclosure made in accordance with section 793 of the Companies Act 2006 (iii) BOTH (i) AND (ii) 3. Name of person discharging managerial responsibilities/director: DR JOHN GORDON (DIRECTOR) AND MRS DIANA MADELEINE GORDON (SPOUSE) 4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person: AS IN 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest: AS IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares: ORDINARY 25p SHARES 7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them: NOT STATED 8. State the nature of the transaction: NOT STATED 9. Number of shares, debentures or financial instruments relating to shares acquired: DR JOHN GORDON PURCHASED 10,000 ORDINARY SHARES AT 350.25 PENCE PER ORDINARY SHARE 10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage): 0.02% 11. Number of shares, debentures or financial instruments relating to shares disposed: MRS DIANA MADELEINE GORDON SOLD 10,000 ORDINARY SHARES AT 350.00 PENCE PER ORDINARY SHARE 12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage): 0.02% 13. Price per share or value of transaction: SEE ABOVE 14. Date and place of transaction: 4 MARCH 2013 - LONDON 15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage): 70,000 ORDINARY SHARES 0.11% 16. Date issuer informed of transaction: 5 MARCH 2013 If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 17. Date of grant: - 18. Period during which or date on which it can be exercised: - 19. Total amount paid (if any) for grant of the option: - 20. Description of shares or debentures involved (class and number): - 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise: - 22. Total number of shares or debentures over which options held following notification: - 23. Any additional information: 24. Name of contact and telephone number for queries: MARK POPE, FOR AND ON BEHALF OF FROSTROW CAPITAL LLP, COMPANY SECRETARY TEL: 020 3 008 4913 Name and signature of duly authorised officer of issuer responsible for making notification: MARK POPE Date of notification: 5 MARCH 2013 - END -
Investor Meets Company
UK 100

Latest directors dealings